Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients.

Kelleher MT, Fruhwirth G, Patel G, Ofo E, Festy F, Barber PR, Ameer-Beg SM, Vojnovic B, Gillett C, Coolen A, Kéri G, Ellis PA, Ng T.

Target Oncol. 2009 Sep;4(3):235-52. doi: 10.1007/s11523-009-0116-y. Epub 2009 Sep 16. Review.

2.

Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.

Shukla HD, Mahmood J, Vujaskovic Z.

Cancer Lett. 2015 Dec 1;369(1):28-36. doi: 10.1016/j.canlet.2015.08.003. Epub 2015 Aug 11. Review.

PMID:
26276717
3.

Proteomics as a guiding tool for more effective personalized therapy.

Lee JM, Kohn EC.

Ann Oncol. 2010 Oct;21 Suppl 7:vii205-10. doi: 10.1093/annonc/mdq375. Review.

4.

Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.

Zhou L, Wang K, Li Q, Nice EC, Zhang H, Huang C.

Expert Rev Proteomics. 2016;13(4):367-81. doi: 10.1586/14789450.2016.1159959. Epub 2016 Mar 16. Review.

PMID:
26923776
5.

Prediction of individual response to anticancer therapy: historical and future perspectives.

Unger FT, Witte I, David KA.

Cell Mol Life Sci. 2015 Feb;72(4):729-57. doi: 10.1007/s00018-014-1772-3. Epub 2014 Nov 12. Review.

6.
7.

Molecular profiling of signalling pathways in formalin-fixed and paraffin-embedded cancer tissues.

Berg D, Hipp S, Malinowsky K, Böllner C, Becker KF.

Eur J Cancer. 2010 Jan;46(1):47-55. doi: 10.1016/j.ejca.2009.10.016. Review.

PMID:
19914823
8.

Proteomics in cancer research: Are we ready for clinical practice?

Maes E, Mertens I, Valkenborg D, Pauwels P, Rolfo C, Baggerman G.

Crit Rev Oncol Hematol. 2015 Dec;96(3):437-48. doi: 10.1016/j.critrevonc.2015.07.006. Epub 2015 Aug 12. Review.

PMID:
26277237
9.

Towards defining biomarkers indicating resistances to targeted therapies.

Stehle F, Schulz K, Seliger B.

Biochim Biophys Acta. 2014 May;1844(5):909-16. doi: 10.1016/j.bbapap.2013.11.006. Epub 2013 Nov 20. Review.

PMID:
24269379
10.

Proteomic and metabolic prediction of response to therapy in gastric cancer.

Aichler M, Luber B, Lordick F, Walch A.

World J Gastroenterol. 2014 Oct 14;20(38):13648-57. doi: 10.3748/wjg.v20.i38.13648. Review.

11.

Plasma membrane proteomics and its application in clinical cancer biomarker discovery.

Leth-Larsen R, Lund RR, Ditzel HJ.

Mol Cell Proteomics. 2010 Jul;9(7):1369-82. doi: 10.1074/mcp.R900006-MCP200. Epub 2010 Apr 8. Review.

12.

Metastatic biomarker discovery through proteomics.

Brinton LT, Brentnall TA, Smith JA, Kelly KA.

Cancer Genomics Proteomics. 2012 Nov;9(6):345-55. Review.

PMID:
23162074
13.

Oncoproteomics: Trials and tribulations.

Zhou L, Li Q, Wang J, Huang C, Nice EC.

Proteomics Clin Appl. 2016 Apr;10(4):516-31. doi: 10.1002/prca.201500081. Epub 2015 Dec 9. Review.

PMID:
26518147
14.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
15.

Mass spectrometry-based proteomics: from cancer biology to protein biomarkers, drug targets, and clinical applications.

Jimenez CR, Verheul HM.

Am Soc Clin Oncol Educ Book. 2014:e504-10. doi: 10.14694/EdBook_AM.2014.34.e504. Review.

16.
17.

Proteomics of cancer of hormone-dependent tissues.

Tyson DR, Ornstein DK.

Adv Exp Med Biol. 2008;630:133-47. Review.

PMID:
18637489
18.

Prognostic and Predictive Biomarkers in Cancer.

Nair M, Sandhu SS, Sharma AK.

Curr Cancer Drug Targets. 2014;14(5):477-504. Review.

PMID:
24807144
19.

The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.

Workman P.

Cancer Chemother Pharmacol. 2003 Jul;52 Suppl 1:S45-56. Epub 2003 Jun 18. Review.

PMID:
12819933
20.

The proteomics of formalin-fixed wax-embedded tissue.

Vincenti DC, Murray GI.

Clin Biochem. 2013 Apr;46(6):546-51. doi: 10.1016/j.clinbiochem.2012.10.002. Epub 2012 Oct 9. Review.

PMID:
23063984

Supplemental Content

Support Center